Regeneus to fast track human stem cell osteoarthritis therapies in Japan – Proactive Investors Australia
|
Regeneus to fast track human stem cell osteoarthritis therapies in Japan
Proactive Investors Australia Chief executive officer Professor Graham Vesey added the Japanese law provided the company with a well-defined pathway to fast-track the clinical trial and potential approval of its new human off-the-shelf cell therapy to treat osteoarthritis and other … |
